Docetaxel Injections Docet

Product/Composition Docetaxel
Strength 20mg, 80mg, 120mg
Form Injection
Production Capacity 10 Million Vials/Month
Packaging 1 Vial / Box
Therapeutic use Breast Cancer / Lung Cancer / Prostate Cancer / Gastric Cancer
Package Insert/Leaflet Available upon request
Brand Name Docet

Docet contains Docetaxel, a taxane-based antineoplastic medicine used as part of chemotherapy regimens for several types of cancer.

Docetaxel works primarily by promoting the stabilization of microtubules and preventing their normal disassembly. This disrupts cell division and inhibits the proliferation of rapidly dividing cancer cells.

Docetaxel is administered by intravenous infusion and is commonly used in combination with other anticancer medicines depending on the type and stage of cancer.

What is Docetaxel?

Docetaxel is a taxane chemotherapy agent derived from the taxane family. It interferes with the microtubule network required for cell division, causing cell-cycle arrest and ultimately contributing to cancer-cell death.

It is used in treatment protocols for breast, lung, prostate, gastric, and head and neck cancers, among other selected malignancies.

Benefits / Uses

Docet (Docetaxel) may be used as part of specialist chemotherapy regimens for:

  • Breast cancer
  • Non-small cell lung cancer (NSCLC)
  • Metastatic prostate cancer
  • Gastric or gastroesophageal adenocarcinoma
  • Head and neck cancers
  • Other selected solid tumors according to established oncology protocols

Docetaxel may be administered alone or in combination with other anticancer medicines depending on the treatment regimen.

Dosage Guidelines

Docetaxel dosage is individualized according to the cancer type, treatment regimen, body surface area, organ function, previous treatment, and patient-specific factors.

  • Administer by intravenous infusion under qualified oncology supervision.
  • A corticosteroid premedication is commonly prescribed to reduce the risk of fluid retention and hypersensitivity reactions.
  • Complete blood counts should be monitored because Docetaxel can cause significant neutropenia.
  • Liver function should be assessed before treatment because hepatic impairment can increase toxicity.
  • Dose modifications or treatment delays may be required according to blood counts, liver function, and adverse effects.
  • Patients should be monitored during infusion for hypersensitivity reactions.

Wholesale & Supply

Docet (Docetaxel Injection) may be supplied for pharmaceutical wholesale, institutional procurement, and export markets, subject to applicable regulatory requirements.

Bulk procurement enquiries may include:

  • Available strengths and presentations
  • Packaging configuration
  • Certificate of Analysis (CoA)
  • Batch documentation
  • Manufacturing documentation
  • Export and shipping documentation

Buying Online

Docetaxel is a prescription chemotherapy medicine and should be sourced through authorized pharmaceutical distributors, hospitals, or licensed healthcare channels.

It must be prepared and administered by qualified healthcare professionals experienced in handling cytotoxic medicines.

Reviews

Individual responses to Docetaxel vary depending on cancer type, disease stage, treatment regimen, dosage, and patient-specific factors. Treatment response and tolerability should be evaluated by the treating oncology team.

Quality Assurance

Docet (Docetaxel Injection) should undergo appropriate pharmaceutical quality-control testing according to applicable standards, including relevant testing for identity, potency, purity, sterility, and other formulation-specific quality requirements.

Frequently Asked Questions

What is Docet used for?

Docet contains Docetaxel and is used as part of chemotherapy regimens for breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, head and neck cancers, and selected other solid tumors.

What type of medicine is Docetaxel?

Docetaxel is a taxane-based cytotoxic chemotherapy medicine.

How does Docetaxel work?

Docetaxel stabilizes microtubules and prevents their normal disassembly, disrupting cell division and inhibiting the growth of rapidly dividing cancer cells.

How is Docet administered?

Docetaxel is administered by intravenous infusion under the supervision of qualified healthcare professionals.

Is Docetaxel used for breast cancer?

Yes. Docetaxel is an established component of several chemotherapy regimens used to treat breast cancer.

Is Docetaxel used for prostate cancer?

Yes. Docetaxel is used in specific treatment regimens for advanced or metastatic prostate cancer.

What are the common side effects of Docetaxel?

Potential adverse effects include neutropenia, anemia, fatigue, nausea, diarrhea, mouth sores, hair loss, peripheral neuropathy, nail changes, and fluid retention.

Why are corticosteroids given with Docetaxel?

Corticosteroid premedication is commonly used to reduce the risk and severity of Docetaxel-associated fluid retention and hypersensitivity reactions.

Does Docetaxel require blood-count monitoring?

Yes. Regular complete blood counts are important because Docetaxel can cause significant suppression of bone-marrow function, particularly neutropenia.

Who should administer Docet?

Docet should be prescribed and administered by qualified healthcare professionals experienced in cancer chemotherapy.

Conclusion

Docet (Docetaxel Injection) is a taxane-based cytotoxic chemotherapy medicine used in established treatment protocols for breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, head and neck cancers, and selected other solid tumors. By stabilizing microtubules and disrupting cell division, Docetaxel inhibits the proliferation of rapidly dividing cancer cells. Because treatment can cause significant myelosuppression, hypersensitivity reactions, fluid retention, and other toxicities, administration requires specialist oncology supervision and appropriate monitoring.